Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
The Role of B-Cell Depletion in MS Care
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Navigating Emerging Biomarkers in MS Care
New Therapies, New Strategy: Rethinking MG Inpatient Care
Outcome Measures Capture Progression in Late-Onset TK2d
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
More Than a Myopathy: The Lived Experience of TK2d
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.